Table 3.
Adjusted cumulative incidence of adverse events (AEs)
| All patients | Acute patients | Elective patients | |
| All AEs | |||
| Incidence 30 days | 28.4 (25.0 to 32.3) | 51.4 (44.0 to 59.5) | 17.2 (14.0 to 21.1) |
| Incidence 90 days | 29.5 (26.0 to 33.8) | 52.1 (45.0 to 60.2) | 18.6 (15 to 22.7) |
| Preventable AEs | |||
| Incidence 30 days | 22.2 (19.0 to 25.6) | 40.6 (35 to 47.2) | 13.9 (11.0 to 17.5) |
| Incidence 90 days | 23.4 (20.0 to 26.8) | 41.1 (36.0 to 48.1) | 15.3 (12.0 to 19.2) |
| Major AEs | |||
| Incidence 30 days | 13.4 (11.0 to 15.6) | 21.4 (18.0 to 25.7) | 10.1 (8.0 to 13.1) |
| Incidence 90 days | 14.7 (12.0 to 17.2) | 22.1 (19.0 to 26.2) | 11.6 (9.0 to 14.9) |
All results are in %, 95% CI in brackets.